EUVIMEDEUVIMED entdecken
Crossref

Leukemia confers a durable imprint on healthy hematopoietic stem and progenitor cells

Ding-Wen Chen, Julie M Schrey, Eric K Wafula, Jian-Meng Fan, Sarah E Adams, Deanne M Taylor, Peter Kurre

Cancer Letters · 2025

DOI: 10.1016/j.canlet.2025.217590 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2025. Verfasst von Ding-Wen Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Comprehensive Bone Marrow Failure Center, Division of Hematology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, US…. Hauptthemen laut MEDLINE: Hematopoietic Stem Cells, Leukemia, Myeloid, Acute. Die Arbeit nennt 20 Literaturangaben. Gefördert von: Alex's Lemonade Stand Foundation for Childhood Cancer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent models of infection and experimental inflammation reveal that hematopoietic stem and progenitor cells (HSPCs) can generate a memory of the exposure. While the acute inflammatory activity rapidly resolves, cells acquire a heightened capacity to respond to subsequent stimulation. Inflammation is also a constitutive feature of cancer, including hematologic malignancies. Here, we adapt a translationally relevant model of acute myeloid leukemia (AML) to determine if inflammation in the bone marrow (BM) niche durably reprograms resident healthy HSPCs. To simulate the onset of malignancy and the subsequent remission, we generated hematopoietic chimera composed of healthy HSPCs and HSPCs bearing an inducible oncogenic human MLL-AF9 translocation expression cassette, a validated model of AML. Results show that the exposure to AML blasts in the BM leaves healthy HSPCs with transcriptomic changes and a shift to glycolytic metabolism during experimental remission. A secondary challenge of AML-experienced animals results in gene expression changes in inflammatory and metabolic pathways. These modified responses coincide with altered chromatin accessibility in AML-experienced HSPCs. Altogether, our observations provide first evidence for the durable inflammatory reprogramming of healthy HSPCs in the cancer microenvironment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem CellsLeukemia, Myeloid, AcuteHumansAnimalsMiceTumor MicroenvironmentOncogene Proteins, FusionInflammationMyeloid-Lymphoid Leukemia ProteinDisease Models, Animal

Substanzen

Oncogene Proteins, FusionMLL-AF9 fusion protein, humanMyeloid-Lymphoid Leukemia Protein

Autor:innen und Institutionen

  • Comprehensive Bone Marrow Failure Center, Division of Hematology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Comprehensive Bone Marrow Failure Center, Division of Hematology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, USA; Perelman School of Medicine, University of Pennsylvania, Philadelph…

Förderung

  • Alex's Lemonade Stand Foundation for Childhood Cancer

Zitieren

APA

Chen, D. W., Schrey, J. M., Wafula, E. K., Fan, J. M., Adams, S. E., Taylor, D. M., & Kurre, P. (2025). Leukemia confers a durable imprint on healthy hematopoietic stem and progenitor cells. Cancer Letters. https://doi.org/10.1016/j.canlet.2025.217590

Vancouver

Chen DW, Schrey JM, Wafula EK, Fan JM, Adams SE, Taylor DM, et al. Leukemia confers a durable imprint on healthy hematopoietic stem and progenitor cells. Cancer Letters. 2025. doi:10.1016/j.canlet.2025.217590

BibTeX
@article{Chen2025,
  author = {Chen, Ding-Wen and Schrey, Julie M and Wafula, Eric K and Fan, Jian-Meng and Adams, Sarah E and Taylor, Deanne M and Kurre, Peter},
  title = {Leukemia confers a durable imprint on healthy hematopoietic stem and progenitor cells},
  journal = {Cancer Letters},
  year = {2025},
  doi = {10.1016/j.canlet.2025.217590}
}
Kostenlos starten →